KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Non-cash Items: 2011-2013

  • Nektar Therapeutics' Non-cash Items rose 41.44% to $15.5 million in Q4 2013 from the same period last year, while for Dec 2013 it was $15.5 million, marking a year-over-year increase of 41.44%. This contributed to the annual value of $56.3 million for FY2013, which is 412.84% up from last year.
  • Per Nektar Therapeutics' latest filing, its Non-cash Items stood at $15.5 million for Q4 2013, which was up 41.44% from $11.0 million recorded in Q4 2012.
  • In the past 5 years, Nektar Therapeutics' Non-cash Items registered a high of $15.5 million during Q4 2013, and its lowest value of $11.0 million during Q4 2012.
  • In the last 3 years, Nektar Therapeutics' Non-cash Items had a median value of $11.2 million in 2011 and averaged $12.6 million.
  • In the last 5 years, Nektar Therapeutics' Non-cash Items dropped by 1.81% in 2012 and then spiked by 41.44% in 2013.
  • Quarterly analysis of 3 years shows Nektar Therapeutics' Non-cash Items stood at $11.2 million in 2011, then declined by 1.81% to $11.0 million in 2012, then spiked by 41.44% to $15.5 million in 2013.
  • Its Non-cash Items was $15.5 million in Q4 2013, compared to $11.0 million in Q4 2012 and $11.2 million in Q4 2011.